HOME >> MEDICINE >> NEWS
Targeting mutant B-Raf protein reduces melanoma development

HERSHEY, PA- Researchers at Penn State College of Medicine have identified the mechanism by which the most mutated gene in melanoma, called v599EB-Raf, aids melanoma tumor development demonstrating its importance as a therapeutic target.

"Our studies suggest that using therapies to target and inhibit the function of mutant v599EB-Raf protein could prevent the spread of melanoma and halt tumor growth for those melanomas containing the B-Raf mutation," said Gavin P. Robertson, Ph.D., assistant professor of pharmacology, pathology, and dermatology, Penn State College of Medicine, Penn State Milton S. Hershey Medical Center. "With cases of melanoma increasing at about 4 percent per year and no effective treatments available for advanced-stage disease, it's imperative that we continue to look for important proteins that could be targeted therapeutically. Studies like this one that identify how inhibiting important melanoma regulating proteins reduce melanoma development will lead to a better understanding of the disease, and thus, the development of more effective long-term treatment options for patients."

The study, titled "Mutant V599EB-Raf Regulates Growth and Vascular Development of Malignant Melanoma Tumors," appeared in the March 15, 2005, issue of Cancer Research.

The job of normal non-mutated B-Raf is to relay signals from the cell membrane, which is the boundary of the cell receiving the signals, to the nucleus, which contains genetic material and controls many of the cell's activities. B-Raf is one member of the chain that relays signals playing an important role in cell signaling. The protein is usually only active when needed to relay signals.

In contrast, mutant B-Raf is active all the time, which disrupts the chain's normal function. Previous studies have shown B-Raf is the most mutated gene in melanomas, present in about 60 percent of human melanomas, but the role mutant B-Raf plays in causing melanoma tumors remained unkn
'"/>

Contact: Valerie Gliem
vgliem@psu.edu
814-865-9481
Penn State
22-Mar-2005


Page: 1 2 3

Related medicine news :

1. Jefferson and Molecular Targeting Technologies, Inc. scientists create vaccine for wildlife rabies
2. Targeting cell fusion as possible way to repair organs, deliver cancer vaccines
3. Targeting bone metastasis and hypercalcemia
4. Effective Obesity Treatment Likely To Require Targeting Of Multiple Weight Control Systems
5. Myosin mutant points to human origins
6. Mechanism of RNA recoding: New twists in brain protein production
7. Epstein-Barr virus protein crucial to its role in blood cancers
8. Neuronal death and processing of Tau protein in Alzheimers disease
9. CK2 protein sustains colon cancer cells by sabotaging ability to commit suicide
10. Brain synapse formation linked to proteins, Stanford study finds
11. Stat5 protein inhibits spread of breast cancer cells

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/23/2017)... ... August 23, 2017 , ... Nightingale College continues the semiannual Give Back Day ... time Nightingale College dedicates to serving and volunteering for organizations that provide indispensable resources ... or those that need a little extra help. , The College’s Give Back ...
(Date:8/23/2017)... , ... August 23, 2017 , ... ... medical professionals, recently launched a new website, http://www.cirrusmedicalstaffing.com . The new site ... to the needs of healthcare professionals who are traveling on short-term assignments to ...
(Date:8/23/2017)... ... August 23, 2017 , ... Boling Vision Center is excited ... and is now seeing patients at Boling Vision Center’s Elkhart & Notre Dame ... and treatment of eye disease, medical retina, high-technology cataract surgery, cosmetic procedures, and ...
(Date:8/23/2017)... CA (PRWEB) , ... August 23, 2017 , ... Silicon ... to announce a new blog archive organized month-by-month. The new rotation of archived blog ... Local Bay Area residents searching information about hair transplantation can review details online and ...
(Date:8/23/2017)... Spring, MD (PRWEB) , ... August 23, 2017 ... ... two categories of the Golden Bridge Awards® - for Risk Management Solution Innovations ... Secure Halo™ online platform released in 2017 and its DHS SAFETY ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... -- Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), today announced ... 30, 2017, and updated its financial outlook for fiscal ... the fiscal third quarter, Hill-Rom reported earnings of $0.09 ... in the prior-year period. These results reflect after-tax special ... primarily related to the non-cash write-down of assets associated ...
(Date:7/27/2017)... July 27, 2017  Zimmer Biomet Holdings, Inc. (NYSE ... ended June 30, 2017.  The Company reported second quarter ... over the prior year period, and an increase of ... basis points of contribution from the LDR Holding Corporation ... second quarter of 2016, or 0.3% on a constant ...
(Date:7/26/2017)... , July 26, 2017 E.I. Medical Imaging ... the Bimini SharkLab to custom design the worlds first ultrasound system ... sharks in their native habitat. In preparation for a ... Channel,s Shark Week, Dr. Guttridge approached EIMI with the ... diagnosis directly to hammerhead sharks underwater. ...
Breaking Medicine Technology:
Cached News: